4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000052
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 220,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2019-01-14 | Grant or award · Stock Option (Right to Buy) | +220,000 | $1.70 | $374,000 | 220,000 | D |
Loading xslF345X03/form4-01142019_090108.xml…